ROCHELLE PARK, NJ â ZRG Partners has announced the findings for the first quarter Global Life Sciences Hiring Index. Hiring activity continued to grow, posting over 20% higher than a year ago. Medical Device hiring increased 20% over last quarter and hiring activity reached historical highs. Despite quarterly decreases in Outsourcing Services and Pharma & Biotech, hiring activity overall was +5% over the prior quarter. ZRG European President and Global Practice Head of Life Sciences, Adam El Din commented, “The demand for medical equipment from emerging countries will outpace demand from developed countries in the next 5 years. While the U.S. and Europe markets are growing at single digits, Indian and Chinese markets are growing at 20â25% a year. The demand for selfâmedication and homeâbased treatment is increasing, with more and more patients resorting to both the diagnosis and treatment of specific diseases at home.” David Fortier, Managing Director â Global Life Sciences added, “Leaders in the various sectors continue to invest heavily on talent and sustain historically robust levels of hiring. While companies seek to build efficient organizations, new technologies and increasingly complex market dynamics create demand for new skill sets and capabilities in the workforce.” About ZRG Partners  ZRG Partners, LLC is a global authority on talent management in the Life Sciences, Pharmaceutical and Medical Device markets. ZRG provides its clients with specialized global market expertise in executive recruitment, consulting and advisory work with a focus on data and analytics to drive great business decisions. The Global Life Sciences Hiring Index analysis utilizes a proprietary algorithm that looks at hiring within selected benchmark companies in three distinct segments. The companies in the index generate over $630 billion in revenues and employ over 1.5 million people globally. ZRG Partners conducts extensive direct market research in developing the data that drives the Index.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.